Pot firm Trulieve Cannabis jumps after Q4 loss narrows
** Canadian pot firm Trulieve Cannabis TRUL.CD soars ~8%
to C$14.33
** Co reports narrower Q4 loss helped by consumer strength
and holiday sales
** Q4 adj. loss of 12 cents/shr, vs year-ago loss of 18
cents/shr
** Q4 net loss of $33 million, compared with year-ago loss
of $77 million
** Stock fell 33% in 2023
(Reporting by Vallari Srivastava in Bengaluru)
((Srivastava.Vallari@thomsonreuters.com;))
Recent news on Trulieve Cannabis
See all newsBrief: Trulieve Announces Uplist To NYSE
Brief: Trulieve Cannabis - Segregates Mixed-Use And Medical Cannabis Businesses To Apply For NYSE Listing - SEC Filing
Brief: Trulieve Announces Proposed Domestication From British Columbia To Delaware
Trulieve Q1 revenue falls 4%, returns to profit
Explainer: How US marijuana reclassification could help cannabis companies